We suggest that Regnase-1, a post-transcriptional regulator, is a causative molecule for the development of abnormal hematopoiesis, and that understanding of the regulatory mechanisms controlling Regnase-1 expression and identifying additional target genes will provide valuable information for therapies targeting AML. Here, ZC3H12A is linked to acute myeloid leukemia.